Period Ending | Mar 30, 2012 | Dec 30, 2011 |
---|
Total Revenue
|
925,000
|
1,003,000
| Cost of Revenue | 562,000 | 623,000 | |
Gross Profit
|
363,000
|
380,000
| |
|
Operating Expenses |
|
Research Development | 28,000 | 27,000 |
|
Selling General and Administrative | 236,000 | 254,000 |
|
Non Recurring |
-
|
-
|
|
Others |
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
| | |
Operating Income or Loss
|
99,000
|
99,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (1,000) |
-
|
|
Earnings Before Interest And Taxes | 98,000 | 99,000 |
|
Interest Expense | 14,000 | 15,000 |
|
Income Before Tax | 84,000 | 84,000 |
|
Income Tax Expense | 21,000 | 32,000 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 63,000 | 52,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | |
Net Income
|
63,000
|
52,000
| Preferred Stock And Other Adjustments |
-
|
-
| |
Net Income Applicable To Common Shares
|
63,000
|
52,000
|
|